Amaero International Ltd (ASX:3DA) is a global specialist in advanced materials manufacturing for the defence, aerospace, and other industrial sectors, developing a critical metals alloy powder manufacturing facility in Tennessee, USA. The company has secured a binding offtake agreement for the supply of C103 additive manufacturing powder, a key milestone in the development of its critical metals powder manufacturing presence in the US. Concurrently, Amaero has raised $20m by way of a placement to institutional investors, which the company anticipates will be the last equity capital raise in the Australian market. Going forward, Amaero says it intends to seek equity capital from strategic US investors. We continue to incorporate Amaero’s guidance that it expects to report an EBITDA loss of $14m in CY2024 and to break-even in CY2025. We have made adjustments to our forecasts based on both timing and product mix as a result of its new offtake agreement. The earnings revisions deliver a base-case valuation of $1.13b or $1.37/share fully diluted (previously $1.40/share). On the current share count of 541m shares, the valuation is $2.09/share.
